These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24957014)

  • 1. Modulation of activity of known cytotoxic ruthenium(III) compound (KP418) with hampered transmembrane transport in electrochemotherapy in vitro and in vivo.
    Hudej R; Miklavcic D; Cemazar M; Todorovic V; Sersa G; Bergamo A; Sava G; Martincic A; Scancar J; Keppler BK; Turel I
    J Membr Biol; 2014 Dec; 247(12):1239-51. PubMed ID: 24957014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy of the antimetastatic compound NAMI-A and electroporation on B16F1 tumour cells in vitro.
    Bicek A; Turel I; Kanduser M; Miklavcic D
    Bioelectrochemistry; 2007 Nov; 71(2):113-7. PubMed ID: 17602896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of electroporation on cytotoxicity of anticancer ruthenium(III) complex KP1339 in vitro and in vivo.
    Hudej R; Turel I; Kanduser M; Scancar J; Kranjc S; Sersa G; Miklavcic D; Jakupec MA; Keppler BK; Cemazar M
    Anticancer Res; 2010 Jun; 30(6):2055-63. PubMed ID: 20651351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
    Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
    J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry.
    Alessio E; Messori L
    Molecules; 2019 May; 24(10):. PubMed ID: 31137659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry.
    Capozzi I; Clerici K; Cocchietto M; Salerno G; Bergamo A; Sava G
    Chem Biol Interact; 1998 May; 113(1):51-64. PubMed ID: 9630847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex.
    Sava G; Capozzi I; Clerici K; Gagliardi G; Alessio E; Mestroni G
    Clin Exp Metastasis; 1998 May; 16(4):371-9. PubMed ID: 9626816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro.
    Scuderi M; Rebersek M; Miklavcic D; Dermol-Cerne J
    Radiol Oncol; 2019 Jun; 53(2):194-205. PubMed ID: 31194692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines.
    Pluim D; van Waardenburg RC; Beijnen JH; Schellens JH
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):71-8. PubMed ID: 15034754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent.
    Lisec B; Markelc B; Ursic Valentinuzzi K; Sersa G; Cemazar M
    Front Immunol; 2023; 14():1189960. PubMed ID: 37304301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion.
    Bergamo A; Stocco G; Casarsa C; Cocchietto M; Alessio E; Serli B; Zorzet S; Sava G
    Int J Oncol; 2004 Feb; 24(2):373-9. PubMed ID: 14719114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma.
    Ursic K; Kos S; Kamensek U; Cemazar M; Scancar J; Bucek S; Kranjc S; Staresinic B; Sersa G
    Bioelectrochemistry; 2018 Feb; 119():161-171. PubMed ID: 29024870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the Ru(III) complexes [mer-RuCl3(DMSO)2Im]degrees and Na[trans-RuCl4(DMSO)Im] on solid mouse tumors.
    Sava G; Pacor S; Mestroni G; Alessio E
    Anticancer Drugs; 1992 Feb; 3(1):25-31. PubMed ID: 1623212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]: mechanism of the selective action investigated on mouse tumors.
    Sava G; Clerici K; Capozzi I; Cocchietto M; Gagliardi R; Alessio E; Mestroni G; Perbellini A
    Anticancer Drugs; 1999 Jan; 10(1):129-38. PubMed ID: 10194556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hydrolysis mechanism of the anticancer ruthenium drugs NAMI-A and ICR investigated by DFT-PCM calculations.
    Vargiu AV; Robertazzi A; Magistrato A; Ruggerone P; Carloni P
    J Phys Chem B; 2008 Apr; 112(14):4401-9. PubMed ID: 18348562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
    Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E
    J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structural characterization, solution chemistry, and preliminary biological studies of the ruthenium(III) complexes [TzH][trans-RuCl4(Tz)2] and [TzH][trans-RuCl4(DMSO)(Tz)].(DMSO), the thiazole analogues of antitumor ICR and NAMI-A.
    Mura P; Camalli M; Messori L; Piccioli F; Zanello P; Corsini M
    Inorg Chem; 2004 Jun; 43(13):3863-70. PubMed ID: 15206867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion.
    Gava B; Zorzet S; Spessotto P; Cocchietto M; Sava G
    J Pharmacol Exp Ther; 2006 Apr; 317(1):284-91. PubMed ID: 16368900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation.
    Cemazar M; Pipan Z; Grabner S; Bukovec N; Sersa G
    Anticancer Res; 2006; 26(3A):1997-2002. PubMed ID: 16827135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro.
    Fiorentzis M; Kalirai H; Katopodis P; Seitz B; Viestenz A; Coupland SE
    Neoplasma; 2018; 65(2):210-215. PubMed ID: 29534581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.